Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Another antihypertensive drug recalled over possible cancer risk
SAVR volumes alone not predictive of TAVR outcomes—but combined experience is
Will another adjunct to statins fit in the cholesterol drug market?
Vitamin D levels in blood tied to cardiorespiratory fitness
Lower blood pressure, BMI may precede dementia
Canagliflozin becomes first oral diabetes drug approved to reduce MACE
NIH pauses $63M stem cell trial for heart failure amid controversy
Wider thrombectomy window chosen as No. 3 medical innovation for 2019
Taking donor heart at increased disease risk is better than waiting
New risk score distinguishes inpatient strokes from other conditions